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Background: Medication-overuse headache (MOH) is often comorbid with emotional disturbances, contributing to
poorer outcomes. The aims of the present study were to assess the psychometric properties of the Stagnation Scale
in a sample of MOH patients, and to compare two factor models: a three-factor model reported in previous studies
and a proposed bi-factor model.
Methods: Consecutive adult outpatients (N = 310) admitted to the Regional Referral Headache Centre of the
Sant’Andrea Hospital in Rome (Italy) were administered the Stagnation Scale and two questionnaires measuring
depression and perceived disability.
Results: The original three-factor model demonstrated an adequate fit to the data (χ2101 = 238.70; p < 0.001; Root Mean
Square Error of Approximation [RMSEA] = 0.07; 90% CI of RMSEA = 0.06 / 0.08; Comparative Fit Index [CFI] = 0.98;
Weighted Root Mean Square Residual [WRMR] = 0.75). However, the bi-factor model had a comparable or even
better fit, with a RMSEA of 0.05 (90% CI: 0.04 / 0.07), providing strong evidence for an absolute fit to the data
(χ288 = 161.43; p < 0.001; RMSEA = 0.05; 90% CI of RMSEA = 0.04 / 0.07; CFI = 0.99; WRMR = 0.56). The stagnation
general factor and all the group factors correlated significantly and positively with convergent measures.
Conclusions: There is support for the use of the Stagnation Scale in MOH patients, with the goal of better
understanding the role of psychological factors in the evolution and course of the disorder.
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Medication-overuse headache (MOH) is characterized
by headache attacks occurring 15 or more days per
month for at least 3 months and is associated with the in-
take of a medication (e.g., ergotamine, triptan, analgesic)
on ≥10 days/month on a regular basis for ≥3 months [1,2].
Its prevalence in the adult general population is estimated
to be 1-2% [3-8]. MOH may vary between around 4% [9]
and 8% in headache patients referred to neurological
clinics [10], and may be diagnosed in up to 29% of patients
from tertiary referral centers for chronic pain [11].* Correspondence: maurizio.pompili@uniroma1.it
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in any medium, provided the original work is pMOH is often comorbid with emotional disturbances
and disordered personality traits [12,13], which seem to
play a role in the evolution of migraine to MOH and are
associated with poorer outcomes [14]. Psychological dis-
turbances may also be risk factors for a later development
of MOH; for example, a prospective 11-year longitudinal
study demonstrated that anxiety and depression with mus-
culoskeletal and gastrointestinal complaints were risk fac-
tors for MOH, but not for chronic headache (i.e., a form
of headache with attacks occurring 15 or more days per
month for at least 3 months) without medication overuse
[15]. The presence of psychopathology has also been used
to distinguish complicated cases of MOH (MOH Type II)
[16-18]. Thus, it is important to use instruments that can
identify a variety of psychiatric disorders, emotional
disturbances, and disordered personality traits among
patients with MOH who are refractory to usual care [19].s is an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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there is no agreement as to which tests are the most ef-
fective or the most promising in identifying psychological
factors in headache patients. In a review of screening tools
for psychiatric comorbidity in headache patients, Maizels
et al. [19] recommend screening all headache patients at
least for anxiety and depression. Moreover, the authors
suggested more comprehensive multidimensional psychi-
atric screening when patients respond poorly to standard
headache management. They also suggested the use of
some specific instruments such as the Beck Depression
Inventory [21], Beck Anxiety Inventory [22], Patient
Health Questionnaire [23], and Mini-International Neuro-
psychiatric Interview [24].
Recently, our group [25] investigated the role of stagna-
tion, an old diagnostic entity of traditional Chinese medi-
cine, in a sample of 69 patients with chronic migraine to
better understand the beliefs that patients may have re-
garding their autonomy/disability. Our results indicated
that stagnation was associated with higher perceived dis-
ability independent of the severity of depression, and that
it could be useful for predicting perceived disability among
patients with chronic migraine. This pilot study was also
the first investigation assessing the utility of the concept of
stagnation in western patients with chronic headache. Ac-
cording to the traditional Chinese medicine, the stagna-
tion syndrome is characterized by a cluster of mind/body
obstruction-like symptoms such as feeling that something
is stuck in the throat, chest and stomach. The cause of
stagnation is hypothesized to be the repression of emo-
tions [26]. If emotions are repressed for a long time, this
can lead to a number of mind/body dysfunctions, such as
suppressed emotions, especially anger, sleeping distur-
bances, dizziness, fatigue, a feeling of obstruction in swal-
lowing, indigestion and bowel dysfunctions [27]. The
hypothesis that the repression of emotions may lead to
headache is also present in western psychological theories
[28,29]. Recently, Sances and colleagues [14] investigated
personality factors associated with negative outcomes in
MOH patients during a 3-year follow-up study. Utilizing
the Minnesota Multiphasic Personality Inventory, 2nd
edition (MMPI-2) [30], the authors reported that those
who never stopped their drug overuse, compared to
other patients, had higher scores on several dimensions
of the MMPI-2, including hypochondriasis (individuals
with high scores on this scale report the presence of many
somatization-like symptoms), repression (individuals with
high scores on this scale report the use of repression, de-
nial, and rationalization, and the lacking of self-insight,
unwillingness to discuss personal shortcomings, they usu-
ally appear over-controlled), and overcontrolled hostility
(individuals with high scores on this scale report a ten-
dency to use denial and repression of aggressive impulses).
Nicholson et al. [31], while evaluating whether anger andanger expression are different between individuals with
and without headache after controlling for depression and
anxiety, reported that headache patients have higher levels
of anger-in (higher levels of anger-in are indicative of a
failure in expressing anger), even after controlling for
other variables. Headache and migraine have also been
demonstrated to be strong and independent predictors of
the presence of somatic symptoms in patients with major
depression. Furthermore, somatosensory amplification (i.e.,
the tendency to perceive normal bodily sensations as un-
usually intense and disturbing) has been shown to be asso-
ciated with the number of attacks and disability in a small
group of migraine patients [32].
Ng et al. [27,33-35] operationalized the construct of stag-
nation through the development of a new scale: the Stagna-
tion Scale. In their initial study, the authors administered
the Stagnation Scale, the Beck Depression Inventory [36],
and the General Health Questionnaire (GHQ-12) [37] to a
sample of 602 Chinese adults. Stagnation scores were mod-
erately associated with depression, while a different pattern
of associations between depression and demographic vari-
ables emerged suggesting a distinct clinical syndrome [27].
More recently, the authors conducted a confirmatory factor
analysis (CFA) study with a random community sample of
755 adults recruited in Hong Kong [35]. The fit indices for a
three-factor model reported in the previous studies were not
completely satisfactory (comparative fit index [CFI] = 0.94,
root mean square error of approximation [RMSEA] = 0.09,
standardized root mean square residual [SRMR] = 0.04);
however, when the authors allowed residual covariance be-
tween items 15 and 16, the resultant model fit improved
and was deemed adequate (CFI = 0.95; RMSEA= 0.08 [90%
CI of RMSEA= 0.07 / 0.08]; SRMR= 0.04) [35]. The three
dimensions are Overattachment, Body–Mind Obstruction,
and Affect–Posture Inhibition [27,33,34]. Items included in
the Overattachment subscale investigate preoccupation or
fear of losing what one possesses, being not as accomplished
as others, and/or being unable to let go of some matters. In
Body–mind Obstruction, the theme is somatic obstruction-
like symptoms such as a feeling that the stomach is
clogged and that something is obstructing the throat. In
Affect–Posture inhibition, the themes are being overly self-
conscious, heightened awareness and uneasiness, resulting in
inhibited facial expression of affect and postural movement.
Correlational analyses with concurrent measures also indi-
cated that the Stagnation Scale was moderately associated
with the Physical Distress subscale of the Body–Mind–Spirit
Well-Being Inventory (r = 0.59) [38], and strongly re-
lated to the GHQ-12 (r = 0.69) [37] and the anxiety and
depression scores on the Hospital Anxiety and Depres-
sion Scale (HADS; r = 0.76, 0.60, respectively for the
anxiety and the depression subscales) [35,39]. Finally,
using participants’ subjective appraisal of illness condi-
tion as the criterion, the authors carried out a receiver
Table 1 Sociodemographic and clinical characteristics of
the sample (N = 310)
Count Percentage
Men 189 61.0%
Age – Mean (Standard deviation) 48.50 (12.44)
Marital status
Married 205 66.2%
Single 67 21.7%
Widowed 11 3.5%
Divorced 27 8.6%
School attendance ≤ 8 years 103 33.2%
Job
Employed 255 82.2
Unemployed 34 10.9%
Retired 21 6.9%
Migraine without aura 310 100%
Migraine with aura 9 2.9%
Headache onset
Preschool 74 24.0%
Puberty 119 38.3%
Adulthood 117 37.8%
Frequency of attacks: daily 161 52.0%
Familiarity for headache 215 69.5%
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ate the optimal cutoffs on the stagnation score with an
aim of balancing false-positive and false-negative rates
in predicting illness condition by self-appraisal. The re-
searchers reported that the optimally balanced cutoff
points on the Stagnation Scale were 50 for the total score
(false-positive and -negative rates, 0.26 and 0.23, respect-
ively), 27 on the Overattachment subscale (false-posi-
tive and -negative rates, 0.22 and 0.23), 14 on the
Body–Mind Obstruction subscale (false-positive and
-negative rates, 0.21 and 0.23), and 10 on the Affect–Pos-
ture Inhibition (false-positive and -negative rates, 0.24
and 0.26) [35].
Given that our previous research has supported the util-
ity of the concept of stagnation when investigating the psy-
chological health of patients with chronic headache, the
psychometric properties of the Stagnation Scale have not
been evaluated in western patients. Thus, the aim of the
present study was to assess the psychometric properties of
an Italian version of the Stagnation Scale in a sample of
MOH patients. First, we assessed dimensionality of the
Stagnation Scale by means of structural equation modeling
(SEM). Specifically we compared a three-factor model re-
ported in previous studies, with a proposed bi-factor model
[40]. In the bi-factor model, each item loads on a general
factor and a group factor [41]. The general factor explains
the covariance shared by all items. The group factors ac-
count for the covariance independent from the general fac-
tor. The general factor and group factors are uncorrelated
and account for the covariance simultaneously and inde-
pendently for each item. The advantage of the bi-factor
model over the original three-factor model is that it hy-
pothesizes the existence of a latent trait and the quasi-
unidimensionality of the questionnaire. In fact, although
stagnation may manifest itself with psychological, behav-
ioral, and physiological symptoms, it was theorized as a
single factor despite the heterogeneous syndrome with a
common cause of repression of emotions. Moreover, al-
though reporting the validity of a three-factor model, the
authors of the Stagnation Scale calculated a total score
consisting of the sum of the three factor scores. Thus, a bi-
factor model with the presence of a general factor may
conform to the theory better than a structure with 3 first-
order factors, especially if all items load more strongly on
the general factor than on the group factors. Second, we
investigated whether there were sex differences on the
Stagnation Scale scores at the item and scale levels. Previ-
ously, Ng et al. [27], reported sex differences in the Body–
Mind Obstruction factor with women reporting higher
mean scores, but not in the total and the other dimension
scores. Third, we investigated reliability and convergent
validity with depression severity and a measure assessing
patient beliefs about the negative effects the illness has on
his/her health and daily activities. We hypothesized thatthe Stagnation Scale dimensions would have moderate
to strong correlations with these convergent measures.
Lastly, considering Meng, Rosenthal and Rubin’s [42]
approach, we hypothesized that the general factor
would exhibit discriminant validity in its associations
with depression and negative beliefs about the impact
of the illness when compared to group factors.
Methods
Sample and procedures
Participants were 310 adult outpatients (189 men, 121
women) consecutively admitted to the Regional Referral
Headache Centre of the Sant’Andrea Hospital in Rome,
between September 2011 and December 2013. Inclusion
criteria were a diagnosis of MOH, and an age of 18 years
or older. Exclusion criteria were comorbidity with major
disorders of the central nervous system (e.g., Parkinson
disease, dementia, epilepsy), delirium and/or any condition
affecting the patient’s ability to complete the assess-
ment, including refusal of informed consent. The aver-
age age of participants was 48.50 years (Min./Max.: 20/
88; SD = 12.44). Other characteristics of the sample are
reported in Table 1. Patients participated voluntarily in the
study, and each subject provided written informed con-
sent. The study protocol received ethics approval from the
local research ethics review board.
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Patients were administered the Stagnation Scale, the
Beck Depression Inventory – II (BDI-II) [21], and the
Italian Perceived Disability Scale (IPDS) [43].
The Stagnation Scale is a 16-item questionnaire assessing
stagnation syndrome (items are listed in Table 2). Respon-
dents were asked to rate each item on a ten-point anchored
numeric scale (“1” indicating “has not occurred at all” and
“10” indicating “occurring every single moment”), according
to how they felt in the last two weeks. In previous research,
the Cronbach’s alpha for the full scale was 0.91 [27], and
the three subscales had Cronbach’s alphas ranging betweenTable 2 Standardized factor loadings (standard errors) for the
three-factor model)
Items Overattachment Bo
Item 1- I fear losing what I possess. 0.38* (0.06)
0.72* (0.03)
Item 2- I get obsessed with
details about certain matters.
0.45* (0.05)
0.77* (0.03)
Item 3- It concerns me that I am
not as accomplished as others.
0.40* (0.06)
0.71* (0.03)
Item 4- Thinking about troubling
things uses up a lot of my energy.
0.44* (0.04)
0.82* (0.03)
Item 5- I get overly attached to
some matters, unable to let go.
0.49* (0.04)
0.85* (0.03)
Item 6- I moan and sigh. 0.20* (0.06)
0.69* (0.04)
Item 7- I still miss the things
I have already lost.
0.22* (0.06)
0.67* (0.04)
Item 8- I feel as if my stomach is clogged. -
Item 9- I feel as if there is something
obstructing my throat.
-
Item 10- I feel my heart beating disquietly. -
Item 11- My head feels heavy and dizzy. -
Item 12- I have an indescribable fear inside. -
Item 13- My gait is constrained. -
Item 14- My sitting posture is rigid. -
Item 15- My facial expressions are unnatural. -
Item 16- My facial expressions are flat. -
*p < 0.001.0.82 and 0.88. The composite stagnation scale has shown
significant positive correlations with a self-report measure
of depression [27].
We translated and adapted the Italian version of the
Stagnation Scale from an English version provided from
the authors of the measure. One author (MI) translated the
original English version in Italian and a second researcher
(MP) blindly back-translated the measure to the source
language. The back-translated version was submitted to
the authors of the Stagnation Scale, who suggested slight
word changes to four items. After having improved the
Italian version of the questionnaire and revised the back-alternative models (upper: bi-factor model; lower:
dy-Mind obstruction Affect-Posture inhibition Stagnation
- - 0.62* (0.04)
- - 0.64* (0.04)
- - 0.60* (0.04)
- - 0.70* (0.03)
- - 0.71* (0.04)
- - 0.64* (0.04)
- - 0.62* (0.04)
0.36* (0.06) - 0.77 (0.03)
0.83* (0.02)
0.48* (0.06) - 0.76* (0.04)
0.84* (0.03)
0.40* (0.06) - 0.71* (0.03)
0.78* (0.03)
0.08 (0.07) - 0.68* (0.04)
0.70* (0.04)
−0.01 (0.06) - 0.84* (0.03)
0.85* (0.03)
- 0.21* (0.06) 0.78* (0.04)
0.85* (0.03)
- 0.38* (0.07) 0.67* (0.04)
0.78* (0.03)
- 0.62* (0.06) 0.72* (0.04)
0.87* (0.02)
- 0.42* (0.06) 0.72* (0.04)
0.84* (0.03)
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original version of the scale who found no discrepancies
between our version and the original measure. The defini-
tive Italian version of the questionnaire was administered to
a small sample of 5 patients (2 women and 3 men; age
52.80 ± 15.87; range 30/70 years) with chronic headache
who participated in a previous study [25]. They evaluated
items and instructions for their perceived comprehensibility
using a four point Likert scale (extremely easy to under-
stand, quite easy to understand, quite hard to understand,
extremely hard to understand). All the items and the in-
structions were rated as extremely easy or quite easy to
understand from patients.
The IPDS measures people’s beliefs regarding autonomy/
disability and the negative impact the illness has on their
health and daily activities in different situations of life (e.g.,
“my body is weak and unreliable”, “I will have to worry
about my health conditions all my life long”; “I boil over
more easier than in the past”). It is composed of 20 items
rated on a 5-point Likert scale (from completely false to
completely true). The raw scores range from 0 to 80. In a
previous study, the IPDS demonstrated good reliability in a
sample of patients with chronic daily headache [43].
The BDI-II is a 21-item self-report inventory designed
to assess the presence and severity of depressive symp-
toms according to the DSM-IV criteria. Respondents
have to endorse specific statements that reflect their
feelings over the last two weeks. Each statement is rated
on a 4-point Likert scale ranging from 0 to 3 on the
basis of symptom severity, which yields a summed mini-
mum score of 0 and a maximum score (indicative of
high depressive symptomology) of 63. An example of an
item on the BDI-II is “Sadness”, with response options
being 0 (I do not feel sad), 1 (I feel sad much of the
time), 2 (I am sad all of the time), and 3 (I am so sad or
unhappy that I can’t stand it). Good estimates of internal
consistency and concurrent validity have been demon-
strated for the Italian version of the BDI-II [44,45].
Statistical analysis
To test the fit of the three-factor and the bi-factor
models, the data were subjected to a confirmatory fac-
tor analysis (CFA) by means of Mplus 6.0 [46]. The ex-
traction of the factors was conducted employing the
Mean- and Variance-adjusted Weighted Least Square
(WLSMV) estimation method on a polychoric correlation
matrix. Model fit was assessed using the following indices:
1) the RMSEA, a measure of absolute fit. Values between
0.05 and 0.08 are indicative of good adequacy of the model,
and below 0.05 deemed strong evidence of absolute fit
[47,48]; 2) the CFI. Values greater than 0.95 / 0.96 for these
indicators are indicative of good model fit; 3) the Weighted
Root Mean Square Residual (WRMR): Yu [49] recommend
that a model with a WRMR of less than 1.0 indicates goodfit; and 4) the chi-squared (χ2) test. P-values greater than
0.05 indicate that the model is adequate to the data, al-
though the χ2 test over-reject true models for large samples
or under non-normality [49]. Considering limitations in
the use of χ2 statistic, we also reported the relative χ2 (χ2/
degree of freedom) statistic [50]. The relative χ2 should be
less than 2 for well-fitting models [51], although diverse
values have also been proposed [50,52]. We did not use
any specific test to compare the two models. Although
some statistics have been proposed for comparing the fit
and parsimony of non-nested models (e.g., the Akaike in-
formation criterion, the consistent version of the Akaike
Information Criterion, the Bayesian Information Criterion,
the Expected Cross-Validation Index, or the Vuong’s Likeli-
hood Ratio Test) [53-56], they all require the use of the
maximum likelihood estimator; however they cannot be
computed when using weighted least squares estimators as
we did in this study.
For each item, we reported the standardized lambda co-
efficients (λ) expressing the relationships between the fac-
tor and its observed variables (used to measure the
validity of the indicator; that is, how well they measure the
latent dimension). As measures of reliability, we reported
Cronbach’s alpha (α), McDonald's omega, and inter-item
mean indices of correlation (rii) for tests of homogeneity.
McDonald's omega can be interpreted as the square of the
correlation between the scale score and the latent variable
common to all the indicators in the infinite universe of in-
dicators of which the scale indicators are a subset [57].
McDonald's omega coefficients were calculated with stat-
istical software Factor 9.2 [58]. One-way Fisher exact tests
and t-tests were used to calculate significance of differ-
ences between sex. Convergent validity with the IPDS and
the BDI-II was evaluated by using Pearson’s r indices of
correlations. We used the approach recommended by
Meng, Rosenthal and Rubin [42] to examine discriminant
validity of the general and group factors of the Stagnation
Scale with measures of depression and perceived disability.
This procedure involves performing a Fisher Z transform-
ation on the correlation coefficients so that they can be
compared via a t-test.
Results
Eighteen patients failed to answer one or more items of
the Stagnation Scale and their data were not included in
the structural equation models. An average of 8 patients
(SD = 1) failed to complete each one of the seventeen
items with scarce variation among items (range: 7/10
items). A significant difference between sex was evident
(t301 = 18.20; p < 0.001) with male patients reporting
more non completed items (4.82 ± 0.88 vs. 3.18 ± 0.53) as
compared to their female counterparts. When comparing
sex differences for items mean scores, no significant differ-
ences were found (not reported in the tables).
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Fit statistics for the alternative SEM models are reported
in Table 3. The analyses demonstrated that the original
three-factor model had an adequate fit to the data. How-
ever, the bi-factor model had a comparable or even better
fit, with a RMSEA of 0.05 (90% CI: 0.04 / 0.07) indicating
strong evidence of absolute fit to the data. When inspect-
ing factor loadings of the three-factor model (Table 2), all
of the items significantly loaded on the hypothesized di-
mension; whereas, when examining factor loadings of the
bi-factor model, all the items more strongly loaded on the
general factor than they did on the group factors. Only two
items (items 11 and 12) did not load significantly on the
hypothesized group dimensions (both items were hypothe-
sized to load on the Body-Mind Obstruction dimension),
although they significantly loaded on the general factor.
Psychometric properties of the stagnation scale
Reliabilities and descriptive statistics for all measures ad-
ministered are reported in Table 4. Omega coefficients
were 0.93 for the Stagnation Scale general factor score,
0.87 for Overattachment, 0.85 for Body-Mind Obstruction,
and 0.83 for Affect-Posture Inhibition, indicating that
around 93% of the variance of the Stagnation Scale scores
was attributable to a latent factor common to all test items.
Male and female patients did not differ for their mean
scores on the stagnation general factor or any of the
group dimensions (Table 4). The stagnation general factor
score (BDI-II = 0.67; IPDS = 0.63; r coefficients significant
for p < 0.001), and all the group dimensions (Overattach-
ment: BDI-II = 0.61; IPDS = 0.56; Body-Mind Obstruction:
BDI-II = 0.61; IPDS = 0.57; Affect-Posture Inhibition:
BDI-II = 0.58; IPDS = 0.53; all coefficients significant at
p < 0.001) were significantly and positively correlated with
convergent measures of depression and IPDS scores. Ac-
cording to the approach recommended by Meng et al.
[42], the general factor correlated more strongly (p < 0.01)
with the convergent measures of depression and perceived
disability than the group factors.
Discussion
Our results suggest that the three-factor structure re-
ported in previous studies assessing the characteristics
of the original version of the Stagnation Scale [27,33-35]
is adequate to represent the structure of the Italian ver-
sion of the Stagnation Scale; however, the bi-factor
model had comparable or even better fit to the data, andTable 3 Fit statistics for the alternative models (Estimator: Me
Chi-Square (χ2) Relative
chi-square (χ2/df)
Root mean squ
approximation (R
Three-factor model 238.70* 2.36 0.07 (0.06
Bi-factor model 161.43* 1.83 0.05 (0.04
*Significant for p < 0.001.the RMSEA suggested strong evidence of absolute fit to
the data of the latter model. This finding suggests that a
general factor common to all the sixteen items of the
Stagnation Scale and three specific latent factors underlying
groups of items are simultaneously present. Furthermore,
items loaded more strongly on the general factor than on
the group factors and the McDonald's omega indicated that
the general factor was able to capture a large part of the
variance of the test scores. These results suggest that the
structure of this instrument can be considered mostly unidi-
mensional, and are in line with the theory which defines
stagnation as a single yet heterogeneous syndrome manifest-
ing itself with psychological, behavioral, and physiological
symptoms. Thus, a bi-factor model with the presence of a
general factor may be able to capture a large part of the vari-
ance of the test scores, and three group factors correlated
only because the single general factor may conform well to
the theory. Our results are also consistent with original au-
thors of the Stagnation Scale who report a total score along
with the three dimensions scores.
The Stagnation scores were strongly associated with
depression severity and with patients’ beliefs about the
negative effects the illness has on their health and daily
activities. This is consistent with previous studies conducted
in Chinese samples [27], although our sample demonstrated
correlation coefficients greater than those reported in the
older Chinese study. Specifically, the Chinese study authors
reported correlation coefficients ranging from 0.37 to 0.55
between Stagnation scores and the Beck Depression Inven-
tory [27], which were lower than those reported in the more
recent study with a correlation coefficient of 0.60 between
Stagnation scores and the HADS depression subscale [35].
Despite the strong association between depression severity
and stagnation, the stagnation scale still has a large amount
of unique variance and should be considered a construct in-
dependent from depression and anxiety, as indicated by the
results of the study conducted by Ng et al. [35]. More im-
portantly, stagnation scores are also strongly associated with
negative beliefs about the effects of the illness on health and
daily activities, and as demonstrated in our previous study
[25], they were able to predict patients’ beliefs regarding
one’s own perceived disability independent of depression
severity.
Stagnation total scores showed a different pattern of cor-
relations with depression and perceived disability when
compared with group factors, indicating discriminant valid-
ity in its association with depression and perceived disability.an- and Variance-adjusted Weighted Least Square)
are error of
MSEA) (90%CI)
Comparative
Fit Index (CFI)
WRMR (Weighted root
mean square residual)
Degree of
freedom (df)
/0.08) 0.98 0.75 101
/0.07) 0.99 0.56 88
Table 4 Descriptive statistics and reliability indices (n = 310)
M (SD) Men n = 189 Women n = 121 t-test (DF = 309) P Cronbach alpha Inter-item mean correlation
Stagnation total score 51.64 (29.70) 50.81 (28.66) 52.94 (31.34) −0.61 0.54 0.93 0.44
Overattachment 24.78 (14.61) 24.15 (13.92) 25.79 (15.64) −0.96 0.34 0.87 0.49
Body-Mind obstruction 16.61 (10.57) 16.66 (10.29) 16.54 (11.04) 0.09 0.93 0.85 0.53
Affect-Posture inhibition 10.36 (8.18) 10.21 (7.94) 10.61 (8.56) −0.42 0.68 0.83 0.56
BDI-II 11.15 (9.43) 11.74 (9.65) 10.56 (9.98) 1.04 0.30 0.92 0.36
BDI-II≥ 20 16.4% 16.6% 16.1% - 0.52 - -
IPDS 26.09 (16.63) 27.48 (16.76) 23.95 (16.27) 1.82 0.07 0.92 0.36
BDI-II = Beck Depression Inventory – II; IPDS = Italian Perceived Disability Scale.
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vergent measures of depression and perceived disability than
group factors, possibly because the group factors tap only
one single aspect of the stagnation symptomatology, either
psychological or physiological symptoms; whereas, it may be
the coexistence of perceived psychological, behavioral, and
physiological symptoms that is particularly burdensome for
patients.
To date, numerous psychometric instruments have
been used in studies involving headache patients; how-
ever, an agreement has not been reached as to which
tests are most effective in identifying psychological fac-
tors in this population [20]. Although screening for de-
pression and anxiety in headache patients in primary
care settings is recommended, more comprehensive as-
sessment of psychopathology and psychological factors is
necessary among patients who respond poorly to standard
headache management or with patients attending head-
ache specialty settings [19]. The Stagnation Scale may be
used to assess the presence of a cluster of somatization-
like symptoms, and preoccupations and fears. The assess-
ment of stagnation could be useful considering that past
literature has reported that the presence of somatosensory
amplification may be predictive of the number of attacks
and disability in migraine patients [32] or negative beliefs
that the impact the illness has on them [25]. Furthermore,
considering its strong association with depression and the
independency of this construct, the Stagnation Scale can
be used to discriminate complex MOH cases (MOH Type
II) characterized by the comorbidity with multiple psychi-
atric disorders and a long history of relapses [59]. Another
strength of the Stagnation Scale is the fact that its proper-
ties have been evaluated in a large sample of chronic head-
ache patients; whereas, other commonly used measures
have been investigated with different populations. Never-
theless, we must also consider the fact that the stagnation
syndrome is not part of the western tradition, and this con-
struct has not been previously examined among western
patients or in the general population, so our results may
not be generalizable to other populations. For example, the
high presence of male patients in our sample may have
had an impact on our results, although male and femalepatients did not differ in their scores on the Stagnation
Scale. Future studies with larger samples should investigate
the invariance of the structure between sex groups.
Strengths and limitations of the study
We have to consider our study results in light of some limi-
tations. For example, we only used self-reported measures
which could have been biased by social desirability [60,61],
and our results are not generalizable to patients with other
diagnoses. Furthermore, although we evaluated the associ-
ation between stagnation and depression, we did not exam-
ine whether stagnation was also associated with anxiety or
other forms of psychopathology. For instance, we did not as-
sess the presence of comorbid mood or anxiety disorders,
although previous research has suggested that psychiatric
disorders may be present in a high percentage of patients
[62-64]. Nonetheless, to our knowledge, this is the first study
to evaluate the psychometric properties of the Stagnation
Scale in a large western sample of MOH patients. However,
future research is needed and should focus on the study of
other psychometric properties of the Stagnation Scale (e.g.,
test-retest reliability and predictive validity).
Conclusion
We found support for the use of the Italian version of the
Stagnation Scale in patients with MOH, with the goal of
better understanding the role of psychological factors on
the evolution and course of the disorder. In fact, MOH
patients reported clusters of mind/body obstruction-like
symptoms, such as feeling something stuck in the throat,
chest and stomach, which are correlated with the percep-
tion of one’s own disability.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
MP and MI planned the study design, DE and FR supervised data collection,
MI performed data analysis. All authors contributed in writing the paper.
All authors read and approved the final manuscript.
Acknowledgements
This study was not supported financially by any grants.
Innamorati et al. The Journal of Headache and Pain 2015, 16:2 Page 8 of 9
http://www.thejournalofheadacheandpain.com/content/16/1/2Author details
1Department of Neurosciences, Mental Health and Sensory Organs, Suicide
Prevention Center, Sant’Andrea Hospital, Sapienza University of Rome, Rome,
Italy. 2Department of Psychiatry and Behavioral Sciences, Emory University
School of Medicine, Atlanta, GA, USA. 3Department of Neurosciences,
Rehabilitation, Ophthalmology and Genetics, Section of Psychiatry, University
of Genova, Genova, Italy. 4Department of Clinical and Molecular Medicine,
Sapienza University of Rome and Regional Referral Headache Centre,
Sant’Andrea Hospital, Rome, Italy.
Received: 1 September 2014 Accepted: 26 November 2014
Published: 19 February 2015
References
1. Dodick DW (2006) Clinical practice. Chronic daily headache. N Engl J Med
354:158–165
2. Silberstein SD, Lipton RB, Sliwinski M (1996) Classification of daily and near-daily
headaches: field trial of revised IHS criteria. Neurology 47:871–875
3. Jonsson P, Hedenrud T, Linde M (2011) Epidemiology of medication overuse
headache in the general Swedish population. Cephalalgia 31:1015–1022,
doi:10.1177/0333102411410082
4. Aaseth K, Grande RB, Kvaerner KJ, Gulbrandsen P, Lundqvist C, Russell MB
(2008) Prevalence of secondary chronic headaches in a population-based
sample of 30-44-year-old persons. The Akershus study of chronic headache.
Cephalalgia 28:705–713, doi:10.1111/j.1468-2982.2008.01577.x
5. Colas R, Munoz P, Temprano R, Gomez C, Pascual J (2004) Chronic daily
headache with analgesic overuse: epidemiology and impact on quality of
life. Neurology 62:1338–1342
6. Diener HC, Limmroth V (2004) Medication-overuse headache: a worldwide
problem. Lancet Neurol 3:475–483
7. Evers S, Marziniak M (2010) Clinical features, pathophysiology, and
treatment of medication-overuse headache. Lancet Neurol 9:391–401,
doi:10.1016/S1474-4422(10)70008-9
8. Katsarava Z, Obermann M (2013) Medication-overuse headache. Curr Opin
Neurol 26:276–281, doi:10.1097/WCO.0b013e328360d596
9. Aaseth K, Grande RB, Lundqvist C, Russell MB (2009) What is chronic
headache in the general population? The Akershus study of chronic
headache. Acta Neurol Scand Suppl 189:30–32
10. Evers S, Suhr B, Bauer B, Grotemeyer KH, Husstedt IW (1999) A retrospective
long-term analysis of the epidemiology and features of drug-induced headache.
J Neurol 246:802–809
11. Schmid CW, Maurer K, Schmid DM, Alon E, Spahn DR, Gantenbein AR,
Sandor PS (2013) Prevalence of medication overuse headache in an
interdisciplinary pain clinic. J Headache Pain 14:4, doi:10.1186/1129-2377-14-4
12. Pakalnis A, Butz C, Splaingard D, Kring D, Fong J (2007) Emotional problems
and prevalence of medication overuse in pediatric chronic daily headache.
J Child Neurol 22:1356–1359
13. Rausa M, Cevoli S, Sancisi E, Grimaldi D, Pollutri G, Casoria M, Grieco D, Bisi
A, Cortelli P, Pozzi E, Pierangeli G (2013) Personality traits in chronic daily
headache patients with and without psychiatric comorbidity: an
observational study in a tertiary care headache center. J Headache Pain
14:22, doi:10.1186/1129-2377-14-22
14. Sances G, Galli F, Ghiotto N, Allena M, Guaschino E, Frustaci A, Nappi G,
Tassorelli C (2013) Factors associated with a negative outcome of
medication-overuse headache: a 3-year follow-up (the ‘CARE’ protocol).
Cephalalgia 33:431–443, doi:10.1177/0333102413477737
15. Hagen K, Linde M, Steiner TJ, Stovner LJ, Zwart JA (2012) Risk factors for
medication-overuse headache: an 11-year follow-up study. The Nord-Trondelag
Health Studies. Pain 153:56–61, doi: 10.1016/j.pain.2011.08.018
16. Saper JR, Lake AE 3rd (2006) Medication overuse headache: type I and type
II. Cephalalgia 26:1262, doi:10.1111/j.1468-2982.2006.01198.x
17. Lake AE 3rd (2006) Medication overuse headache: biobehavioral issues and
solutions. Headache 46(Suppl 3):S88–S97, doi:10.1111/j.1526-4610.2006.00560.x
18. Rossi P, Faroni JV, Nappi G (2011) Short-term effectiveness of simple advice
as a withdrawal strategy in simple and complicated medication overuse
headache. Eur J Neurol 18:396–401, doi:10.1111/j.1468-1331.2010.03157.x
19. Maizels M, Smitherman TA, Penzien DB (2006) A review of screening tools
for psychiatric comorbidity in headache patients. Headache 46(Suppl 3):
S98–S109, doi:10.1111/j.1526-4610.2006.00561.x
20. Weeks R, Weier Z (2006) Psychological assessment of the headache patient.
Headache 46(Suppl 3):S110–S118, doi:10.1111/j.1526-4610.2006.00562.x21. Beck AT, Steer RA, Brown GK (1996) Manual for the Beck Depression
Inventory-II. Psychological Corporation, San Antonio, TX
22. Beck AT, Steer RA (1993) Manual for the Beck Anxiety Inventory. The Psychological
Corporation, San Antonio, TX
23. Spitzer RL, Kroenke K, Williams JB (1999) Validation and utility of a self-report version
of PRIME-MD: the PHQ primary care study. Primary care evaluation of mental
disorders. Patient health questionnaire. JAMA 282:1737–1744
24. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E,
Hergueta T, Baker R, Dunbar GC (1998) The Mini-International Neuropsychiatric
Interview (M.I.N.I.): the development and validation of a structured diagnostic
psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl 20):22–33,
quiz 34-57
25. Innamorati M, Pompili M, Fiorillo M, Lala N, Negro A, Del Bono SD, Lester D,
Girardi P, Martelletti P (2013) Overattachment and perceived disability in
chronic migraineurs. Clin Neurol Neurosurg 115:954–958, doi:10.1016/j.
clineuro.2012.09.029
26. Yuen YC, Ren JS, Wang L, Guo KZ (1997) Chinese-English Dictionary of
Traditional Chinese Medicine. People’s Health Publishing, Beijing
27. Ng SM, Chan CLW, Ho DYF, Wong YY, Ho RTH (2006) Stagnation as a
distinct clinical syndrome: comparing ‘Yu’ (stagnation) in traditional Chinese
medicine with depression. Br J Soc Work 36:467–484
28. Blayau P (2008) Migraines and repression. Revue Française de
Psychosomatique 34:121–136
29. Vincent NF (1960) Psychodynamics of a patient with migraine, with a
review of the literature. Am J Psychother 14:589–605
30. Hathaway SR, McKinley JC (1989) MMPI-2: Minnesota Multiphasic Personality
Inventory-2: Manual for Administration and Scoring. University of Minnesota
Press, Minneapolis
31. Nicholson RA, Gramling SE, Ong JC, Buenaver L (2003) Differences in anger
expression between individuals with and without headache after
controlling for depression and anxiety. Headache 43:651–663
32. Yavuz BG, Aydinlar EI, Dikmen PY, Incesu C (2013) Association between
somatic amplification, anxiety, depression, stress and migraine. J Headache
Pain 14:53, doi:10.1186/1129-2377-14-53
33. Ng SM (2008) Operationalising Chinese medicine ‘stagnation’ concept as a
psychological construct. Hong Kong J Psychiatry 18:52
34. Ng SM, Fong TCT (2011) The use of a structured questionnaire to study
stagnation syndrome in traditional Chinese medicine among adults living in
community. J Chin Integr Med 9:22–28
35. Ng SM, Fong TC, Wang XL, Wang YJ (2012) Confirmatory factor analysis of the
stagnation scale-a traditional Chinese medicine construct operationalized for mental
health practice. Int J Behav Med 19:228–233, doi:10.1007/s12529-011-9146-9
36. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for
measuring depression. Arch Gen Psychiatry 4:561–571
37. Goldberg D (1972) The Detection of Mental Illness by Questionnaire.
Oxford University Press, London
38. Ng SM, Yau JKY, Chan CLW, Chan CHY, Ho DYF (2005) The measurement of
body-mind-spirit well-being: toward multidimensionality and transcultural
applicability. Soc Work Health Care 41:33–52
39. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale.
Acta Psychiatr Scand 67:361–370
40. Holzinger KJ, Swineford F (1937) The bi-factor method. Psychometrika 2:41–54
41. Deng N, Wells C, Hambleton R (2008) A confirmatory factor analytic study
examining the dimensionality of educational achievement tests. NERA
Conference Proceedings, Rocky Hill, Connecticut
42. Meng XL, Rosenthal R, Rubin DB (1992) Comparing correlated correlation
coefficients. Psychol Bull 111:172–175
43. Innamorati M, Pompili M, De Filippis S, Gentili F, Erbuto D, Lester D,
Tamburello A, Iacorossi G, Cuomo I, Dominici G, Tatarelli R, Martelletti P
(2009) The validation of the Italian Perceived Disability Scale (IPDS) in
chronic daily headache sufferers. J Headache Pain 10:21–26
44. Balsamo M, Saggino A (2007) Test per l’assessment della depressione nel
contesto italiano: un’analisi critica. Psicoterapia Cognitiva e
Comportamentale 13:167–199
45. Ghisi M, Flebus GB, Montano A, Sanavio E, Sica C (2006) Beck Depression
Inventory-Second Edition. Adattamento Italiano: Manuale. Organizzazioni
Speciali, Firenze
46. Muthén LK, Muthén BO (1998–2010) Mplus User’s Guide, 6th edn. Muthén &
Muthén, Los Angeles, CA
47. Browne MW, Cudek R (1993) Alternative Ways of Assessing Model fit. In: Long JS
(ed) Testing Structural Equation Models. Sage, Newbury Park, CA, pp 136–162
Innamorati et al. The Journal of Headache and Pain 2015, 16:2 Page 9 of 9
http://www.thejournalofheadacheandpain.com/content/16/1/248. Hu L, Bentler PM (1999) Cutoff criteria for fit indexes in covariance structure
analysis: conventional criteria versus new alternatives. Struct Eq Model:
A Multidiscip J 6:1–55
49. Yu CY (2002) Evaluating Cutoff Criteria of Model fit Indices for Latent
Variable Models With Binary and Continuous Outcomes. Thesis for the Title
of Doctor of Philosophy. University of California, Los Angeles
50. Wheaton B, Muthen B, Alwin DF, Summers G (1977) Assessing reliability and
stability in panel models. Sociol Methodol 8:84–136
51. Tabachnick BG, Fidell LS (2013) Using Multivariate Statistics. Pearson
Education, Boston
52. Bollen KA (1989) Structural Equation Modeling With Latent Variables.
Wiley, New York
53. Akaike H (1973) Information Theory and an Extension of the Maximum
Likelihood Principle. In: Petrov BN, Caski F (eds) Proceedings of the Second
International Symposium on Information Theory. Akademiai Kiado,
Budapest, pp 267–281
54. Akaike H (1974) A new look at the statistical model identification. IEE Trans
Autom Control 19:716–723
55. Schreiber JB (2008) Core reporting practices in structural equation
modeling. Res Social Adm Pharm 4:83–97, doi: 10.1016/j.
sapharm.2007.04.003
56. Vuong QH (1989) Likelihood ratio tests for model selection and non-nested
hypotheses. Econometrica 57:307–333
57. McDonald RP (1999) Test Theory: A Unified Treatment. Lawrence Erlbaum
Associates, Mahwah, NJ
58. Lorezo-Seva U, Ferrando PJ (2013) Manual of the Program Factor v. 9.20.
Department de Psicologia. Universitata Rovira i Virgili, Tarragona
59. Negro A, Martelletti P (2011) Chronic migraine plus medication
overuse headache: two entities or not? J Headache Pain 12:593–601,
doi:10.1007/s10194-011-0388-3
60. Maccoby EE, Maccoby NA (1954) The Interview: A Tool of Social Science. In:
Lindzey G (ed) Handbook of Social Psychology. Addison-Wesley, Cambridge,
MA, pp 449–487
61. Arnold HJ, Feldman DC (1981) Social desirability response bias in self-report
choice situations. Acad Manag J 24:377–385
62. Guidetti V, Galli F (2002) Psychiatric comorbidity in chronic daily headache:
pathophysiology, etiology, and diagnosis. Curr Pain Headache Rep 6:492–497
63. Verri AP, Proietti Cecchini A, Galli C, Granella F, Sandrini G, Nappi G (1998)
Psychiatric comorbidity in chronic daily headache. Cephalalgia 18 Suppl
21:45–49
64. Pompili M, Di Cosimo D, Innamorati M, Lester D, Tatarelli R, Martelletti P
(2009) Psychiatric comorbidity in patients with chronic daily headache and
migraine: a selective overview including personality traits and suicide risk.
J Headache Pain 10:283–290, doi: 10.1007/s10194-009-0134-2
doi:10.1186/1129-2377-16-2
Cite this article as: Innamorati et al.: Psychometric properties of the
stagnation scale in medication overuse headache patients. The Journal
of Headache and Pain 2015 16:2.Submit your manuscript to a 
journal and benefi t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the fi eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
